Is the Untested and Dangerous Monkeypox Vaccine About to get an EUA to Avoid Legal Liability for Deaths and Injuries?
We saw throughout the COVID Plandemic that the pharmaceutical industry took advantage of "Public Health Emergency" designations to get the FDA to issue EUAs (emergency use authorization) to get new, untested vaccines into the market as soon as possible without proper testing, and more importantly for the pharmaceutical companies, no legal liabilities. With the W.H.O. and the U.S. Government now declaring monkeypox to be a "Public Health Emergency," could the same thing happen with new vaccines and drugs for monkeypox? The problem in issuing the existing smallpox/monkeypox vaccine an EUA, is that it was already approved by the FDA, even though it has not been tested in the public much beyond the initial trials conducted by the drug company. According to Dr. Meryl Nass, that may not stop them from figuring out a way to get the FDA to issue them an EUA to avoid legal liability: "Although I don't have the full story yet, I am warning you that the moneypox vaccine Jynneos is a huge scam, in every way, including the supposed shortage. I will disclose more about that soon. But since it is actually licensed, the moneypox vaccine (like other licensed drugs and vaccines) has liability attached to it. You can currently sue government program planners, the doctor who recommended it, the manufacturer, etc. if anything goes wrong. To forestall that, some crook came up with the idea of splitting the doses, under the guise of a fake shortage, which provides an excuse to make the lower dose an EUA--in other words, turning it into a product for which you cannot sue anyone if something goes wrong. Pretty clever, eh? Licensed products are not supposed to receive EUAs unless they are used for something different than what they were licensed for. Splitting the dose does not change the fact it is licensed for monkeypox and being used for moneypox. Here is another possible but diabolical reason to split (dilute) the dose: it potentially allows the federal government access to the vials--so the vials won't go straight from the manufacturer to the wholesaler but instead go somewhere else to be diluted. And what is in the diluent?"